ELTROMBOPAG OLAMINE

ELTROMBOPAG OLAMINE was reported 23242 times

ELTROMBOPAG OLAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SERUM COLOUR ABNORMAL 8 0.4000
1 LUNG DISEASE INFECTIVE EXACERBATION 10 0.3704
2 BONE MARROW RETICULIN FIBROSIS 54 0.2093
3 AUTOIMMUNE PANCYTOPENIA 12 0.1319
4 MUCOCUTANEOUS HAEMORRHAGE 17 0.1141
5 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 52 0.1109
6 PLATELET COUNT INCREASED 1127 0.0864
7 PLATELET COUNT ABNORMAL 486 0.0803
8 CLONAL EVOLUTION 8 0.0769
9 IMMUNE THROMBOCYTOPENIA 314 0.0685
10 EVANS SYNDROME 33 0.0669
11 ORAL BLOOD BLISTER 13 0.0650
12 MEGAKARYOCYTES INCREASED 8 0.0645
13 MEGAKARYOCYTES ABNORMAL 7 0.0619
14 PLATELET DISORDER 146 0.0578
15 BONE MARROW MYELOGRAM ABNORMAL 8 0.0460
16 RETICULOCYTOSIS 9 0.0425
17 APLASTIC ANAEMIA 216 0.0413
18 LABELLED DRUG-FOOD INTERACTION ISSUE 7 0.0412
19 PLATELET COUNT DECREASED 4101 0.0384
20 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 19 0.0381
21 MYELOFIBROSIS 109 0.0360
22 SPLENECTOMY 40 0.0344
23 CEREBRAL VENOUS SINUS THROMBOSIS 29 0.0343
24 TRANSPLANT DYSFUNCTION 54 0.0302
25 PETECHIAE 315 0.0302
26 PARVOVIRUS INFECTION 12 0.0297
27 CYSTITIS VIRAL 11 0.0287
28 THROMBOCYTOSIS 100 0.0273
29 ANTIPHOSPHOLIPID SYNDROME 42 0.0261
30 IDIOPATHIC THROMBOCYTOPENIC PURPURA 40 0.0253
31 MARROW HYPERPLASIA 17 0.0249
32 MEAN PLATELET VOLUME INCREASED 15 0.0248
33 CHRONIC MYELOMONOCYTIC LEUKAEMIA 16 0.0242
34 BIOPSY BONE MARROW ABNORMAL 11 0.0242
35 BOREDOM 8 0.0236
36 THROMBOCYTOPENIA NEONATAL 9 0.0214
37 IMMUNE THROMBOCYTOPENIC PURPURA 60 0.0212
38 OESOPHAGEAL ADENOCARCINOMA 10 0.0210
39 HYPERFERRITINAEMIA 9 0.0209
40 PLATELET COUNT 12 0.0207
41 IRON OVERLOAD 22 0.0204
42 EYE COLOUR CHANGE 20 0.0196
43 HAEMORRHAGIC DISORDER 21 0.0193
44 BIOPSY BONE MARROW 9 0.0192
45 MUCOSAL HAEMORRHAGE 22 0.0190
46 PRODUCT SUPPLY ISSUE 135 0.0189
47 DISCOURAGEMENT 44 0.0188
48 PORTAL VEIN THROMBOSIS 59 0.0182
49 CEREBRAL VENOUS THROMBOSIS 33 0.0182
50 PLATELET TRANSFUSION 22 0.0171
51 PARVOVIRUS B19 INFECTION 15 0.0168
52 RETICULOCYTE COUNT DECREASED 7 0.0162
53 RETICULOCYTE COUNT INCREASED 13 0.0161
54 HEAD BANGING 9 0.0158
55 GINGIVAL BLEEDING 207 0.0151
56 SUPERIOR SAGITTAL SINUS THROMBOSIS 12 0.0150
57 T-LYMPHOCYTE COUNT DECREASED 10 0.0147
58 MOUTH HAEMORRHAGE 106 0.0144
59 PULMONARY ARTERY THROMBOSIS 11 0.0143
60 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 8 0.0138
61 BLOOD BILIRUBIN UNCONJUGATED INCREASED 10 0.0138
62 GINGIVAL HYPERTROPHY 20 0.0132
63 ADRENAL HAEMORRHAGE 7 0.0125
64 HAEMOPERITONEUM 10 0.0125
65 CYTOMEGALOVIRUS INFECTION REACTIVATION 53 0.0120
66 HAEMATOLOGICAL MALIGNANCY 34 0.0119
67 RENAL VEIN THROMBOSIS 8 0.0118
68 GRAFT VERSUS HOST DISEASE IN LIVER 8 0.0112
69 MESENTERIC VEIN THROMBOSIS 11 0.0110
70 PNEUMOCYSTIS JIROVECII INFECTION 13 0.0109
71 INVESTIGATION 34 0.0108
72 MYELODYSPLASTIC SYNDROME 155 0.0107
73 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 15 0.0106
74 GRAFT VERSUS HOST DISEASE IN SKIN 23 0.0104
75 METAPNEUMOVIRUS INFECTION 8 0.0102
76 RED BLOOD CELL ABNORMALITY 9 0.0094
77 CUSHINGOID 30 0.0093
78 FULL BLOOD COUNT INCREASED 11 0.0092
79 ACUTE GRAFT VERSUS HOST DISEASE 42 0.0092
80 SPLENIC INFARCTION 16 0.0092
81 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 12 0.0091
82 HAEMORRHAGIC DIATHESIS 32 0.0090
83 SERUM SICKNESS 25 0.0090
84 LYMPHOCYTIC INFILTRATION 9 0.0089
85 ECCHYMOSIS 61 0.0089
86 CHRONIC LYMPHOCYTIC LEUKAEMIA 42 0.0088
87 ABSCESS ORAL 12 0.0087
88 ACUTE LEUKAEMIA 14 0.0087
89 HEPATIC INFECTION 11 0.0086
90 PNEUMONIA FUNGAL 34 0.0086
91 BONE MARROW DISORDER 26 0.0086
92 CEREBRAL TOXOPLASMOSIS 8 0.0086
93 CHRONIC GRAFT VERSUS HOST DISEASE 30 0.0083
94 THERAPY NON-RESPONDER 372 0.0083
95 STENOTROPHOMONAS INFECTION 11 0.0081
96 HYPOFIBRINOGENAEMIA 8 0.0081
97 CYTOGENETIC ABNORMALITY 9 0.0080
98 ACUTE MYELOID LEUKAEMIA 124 0.0079
99 PURPURA 70 0.0079
100 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 7 0.0076
101 OVARIAN DISORDER 7 0.0074
102 HYPERCOAGULATION 14 0.0073
103 GRAFT VERSUS HOST DISEASE 52 0.0072
104 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 15 0.0070
105 TRANSPLANT FAILURE 17 0.0069
106 ARTERIAL THROMBOSIS 13 0.0067
107 AUTOIMMUNE HAEMOLYTIC ANAEMIA 23 0.0067
108 CYTOGENETIC ANALYSIS ABNORMAL 7 0.0067
109 BLAST CELL COUNT INCREASED 7 0.0067
110 PRODUCT AVAILABILITY ISSUE 152 0.0067
111 MONOCYTE COUNT INCREASED 24 0.0066
112 INTRACRANIAL VENOUS SINUS THROMBOSIS 7 0.0065
113 BLOOD BLISTER 20 0.0064
114 CEREBRAL THROMBOSIS 18 0.0064
115 BLOOD BILIRUBIN ABNORMAL 8 0.0062
116 ADENOVIRUS INFECTION 18 0.0062
117 FIBROSIS 19 0.0062
118 SLEEP DEFICIT 13 0.0061
119 DENGUE FEVER 14 0.0061
120 HOSPICE CARE 60 0.0061
121 AORTIC THROMBOSIS 7 0.0061
122 OESOPHAGEAL HAEMORRHAGE 8 0.0060
123 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 16 0.0060
124 HEAVY MENSTRUAL BLEEDING 54 0.0060
125 GASTRIC DILATATION 10 0.0060
126 YELLOW SKIN 28 0.0060
127 BK VIRUS INFECTION 20 0.0059
128 MANTLE CELL LYMPHOMA 9 0.0059
129 INTERMENSTRUAL BLEEDING 33 0.0059
130 ATRIAL THROMBOSIS 12 0.0058
131 BLOOD DISORDER 46 0.0057
132 THERAPEUTIC RESPONSE DELAYED 16 0.0057
133 CYTOPENIA 69 0.0056
134 DECREASED IMMUNE RESPONSIVENESS 55 0.0056
135 THROMBOCYTOPENIA 611 0.0055
136 SPLENOMEGALY 64 0.0055
137 MEAN CELL VOLUME INCREASED 14 0.0054
138 RED BLOOD CELL COUNT INCREASED 15 0.0054
139 CONTUSION 516 0.0054
140 SPLEEN DISORDER 9 0.0053
141 NEUTROPHIL COUNT ABNORMAL 15 0.0053
142 JAUNDICE NEONATAL 10 0.0053
143 LAZINESS 9 0.0053
144 GINGIVAL SWELLING 23 0.0052
145 FULL BLOOD COUNT DECREASED 104 0.0052
146 EPISTAXIS 383 0.0051
147 GASTROINTESTINAL OEDEMA 9 0.0051
148 OCULAR ICTERUS 22 0.0051
149 CYTOMEGALOVIRUS VIRAEMIA 22 0.0049
150 THERAPY PARTIAL RESPONDER 77 0.0049
151 MEAN CELL HAEMOGLOBIN DECREASED 9 0.0049
152 LEUKAEMIA 46 0.0049
153 VENOOCCLUSIVE LIVER DISEASE 24 0.0049
154 VENOUS THROMBOSIS LIMB 10 0.0048
155 BLOOD IRON INCREASED 9 0.0048
156 HEPATIC NEOPLASM MALIGNANT 10 0.0047
157 CONJUNCTIVAL HAEMORRHAGE 18 0.0047
158 BILIRUBIN CONJUGATED INCREASED 11 0.0047
159 CONCOMITANT DISEASE AGGRAVATED 29 0.0047
160 GLIOBLASTOMA 8 0.0047
161 GASTROINTESTINAL WALL THICKENING 7 0.0047
162 BONE MARROW FAILURE 95 0.0047
163 HAEMORRHAGE 487 0.0047
164 BLOOD BILIRUBIN INCREASED 125 0.0046
165 HAEMOGLOBIN INCREASED 21 0.0046
166 LYMPHOCYTE COUNT INCREASED 15 0.0046
167 HAEMOGLOBIN DECREASED 471 0.0046
168 SERUM FERRITIN INCREASED 24 0.0045
169 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 8 0.0045
170 FEELING OF DESPAIR 21 0.0045
171 EMBOLISM 37 0.0045
172 ESSENTIAL HYPERTENSION 8 0.0044
173 HYPERBILIRUBINAEMIA 45 0.0043
174 HYPOACUSIS 187 0.0043
175 HYPOPROTEINAEMIA 8 0.0042
176 HAEMORRHAGE INTRACRANIAL 63 0.0042
177 HAEMOGLOBIN ABNORMAL 27 0.0042
178 RED BLOOD CELL COUNT DECREASED 120 0.0042
179 HAEMOLYTIC ANAEMIA 37 0.0041
180 LIVER DISORDER 182 0.0041
181 RED CELL DISTRIBUTION WIDTH INCREASED 17 0.0041
182 VENOUS THROMBOSIS 16 0.0041
183 SERUM FERRITIN DECREASED 7 0.0040
184 PIGMENTATION DISORDER 25 0.0040
185 THROMBOSIS 319 0.0040
186 PARAPARESIS 7 0.0039
187 HEPATOSPLENOMEGALY 10 0.0039
188 DEATH 3355 0.0039
189 FULL BLOOD COUNT ABNORMAL 41 0.0039
190 MONOPARESIS 7 0.0039
191 STAPHYLOCOCCAL SEPSIS 19 0.0038
192 APLASIA PURE RED CELL 13 0.0038
193 WHITE BLOOD CELL DISORDER 10 0.0037
194 BONE MARROW TRANSPLANT 7 0.0037
195 CHRONIC MYELOID LEUKAEMIA 17 0.0037
196 HAEMATOLOGICAL INFECTION 9 0.0037
197 HAEMATOMA 95 0.0037
198 VENOOCCLUSIVE DISEASE 9 0.0036
199 APLASIA 7 0.0036
200 DISEASE RECURRENCE 170 0.0036
201 HAEMORRHAGE URINARY TRACT 9 0.0035
202 GENE MUTATION 7 0.0035
203 AMMONIA INCREASED 18 0.0035
204 HAEMOLYSIS 27 0.0035
205 CORONARY ARTERY THROMBOSIS 7 0.0035
206 ESCHERICHIA SEPSIS 10 0.0034
207 BILIARY COLIC 10 0.0034
208 THROMBOTIC MICROANGIOPATHY 33 0.0034
209 PULMONARY INFARCTION 8 0.0034
210 PANCYTOPENIA 189 0.0034
211 REHABILITATION THERAPY 13 0.0034
212 ASPERGILLUS INFECTION 22 0.0033
213 BRAIN HERNIATION 10 0.0033
214 URINARY TRACT DISORDER 15 0.0033
215 CORONAVIRUS INFECTION 22 0.0033
216 INTERNAL HAEMORRHAGE 38 0.0033
217 CYTOMEGALOVIRUS INFECTION 55 0.0033
218 DISEASE COMPLICATION 15 0.0033
219 PORTAL HYPERTENSION 10 0.0032
220 CEREBRAL HAEMORRHAGE 115 0.0032
221 DEEP VEIN THROMBOSIS 208 0.0032
222 NEUTROPHIL COUNT DECREASED 130 0.0032
223 RETINAL ARTERY OCCLUSION 8 0.0032
224 PNEUMATOSIS INTESTINALIS 9 0.0032
225 RETINAL VEIN OCCLUSION 9 0.0031
226 MENINGITIS ASEPTIC 14 0.0031
227 SARS-COV-2 TEST POSITIVE 41 0.0031
228 HAEMORRHAGE SUBCUTANEOUS 11 0.0031
229 LUMBAR VERTEBRAL FRACTURE 14 0.0031
230 ISCHAEMIA 14 0.0030
231 BACTERAEMIA 36 0.0030
232 PRODUCT USE IN UNAPPROVED INDICATION 747 0.0030
233 DEMENTIA 84 0.0030
234 HIV INFECTION 9 0.0030
235 EMERGENCY CARE 9 0.0030
236 CEREBRAL INFARCTION 72 0.0029
237 HEPATIC CIRRHOSIS 55 0.0029
238 SUBDURAL HAEMORRHAGE 8 0.0029
239 HERPES SIMPLEX 19 0.0029
240 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 8 0.0029
241 LIVER FUNCTION TEST INCREASED 62 0.0029
242 RESPIRATORY SYMPTOM 8 0.0028
243 GRANULOCYTOPENIA 16 0.0028
244 BLOOD LACTATE DEHYDROGENASE INCREASED 44 0.0028
245 FIBULA FRACTURE 8 0.0028
246 AUTOIMMUNE DISORDER 27 0.0028
247 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 14 0.0027
248 HEPATOMEGALY 27 0.0027
249 NOCARDIOSIS 7 0.0027
250 AUTOIMMUNE HEPATITIS 19 0.0027
251 HYPERTRANSAMINASAEMIA 19 0.0027
252 NEAR DEATH EXPERIENCE 9 0.0027
253 SUBDURAL HAEMATOMA 39 0.0027
254 GUILLAIN-BARRE SYNDROME 13 0.0027
255 IRON DEFICIENCY 12 0.0027
256 LUNG OPACITY 7 0.0027
257 TRANSAMINASES INCREASED 59 0.0027
258 ILLNESS 273 0.0026
259 THROMBOPHLEBITIS SUPERFICIAL 8 0.0026
260 JAUNDICE 71 0.0026
261 BLOOD TEST ABNORMAL 37 0.0026
262 PNEUMONIA BACTERIAL 24 0.0026
263 COMPRESSION FRACTURE 14 0.0026
264 INCREASED TENDENCY TO BRUISE 24 0.0026
265 DIFFUSE LARGE B-CELL LYMPHOMA 20 0.0026
266 HAEMATOCRIT DECREASED 51 0.0026
267 CACHEXIA 13 0.0025
268 LUNG CONSOLIDATION 7 0.0025
269 PULMONARY ALVEOLAR HAEMORRHAGE 14 0.0025
270 PULMONARY EMBOLISM 233 0.0024
271 THERAPY CHANGE 24 0.0024
272 HEPATIC ENZYME INCREASED 166 0.0024
273 WOUND HAEMORRHAGE 9 0.0024
274 IMMUNE SYSTEM DISORDER 32 0.0024
275 LIVER FUNCTION TEST ABNORMAL 70 0.0024
276 HEPATIC ENZYME ABNORMAL 12 0.0024
277 COAGULOPATHY 40 0.0024
278 FURUNCLE 19 0.0024
279 HEPATIC FAILURE 72 0.0024
280 PULMONARY THROMBOSIS 26 0.0024
281 CEREBRAL HAEMATOMA 8 0.0024
282 SEPSIS 263 0.0024
283 HEPATIC ENCEPHALOPATHY 22 0.0024
284 ATYPICAL PNEUMONIA 7 0.0023
285 BENIGN PROSTATIC HYPERPLASIA 12 0.0023
286 NEPHROPATHY TOXIC 26 0.0023
287 THERAPEUTIC RESPONSE DECREASED 140 0.0023
288 BLOOD COUNT ABNORMAL 35 0.0023
289 TRANSFUSION 24 0.0023
290 THROMBOPHLEBITIS 8 0.0023
291 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 125 0.0023
292 ENTEROCOCCAL INFECTION 11 0.0023
293 LABORATORY TEST ABNORMAL 67 0.0023
294 BRAIN DEATH 7 0.0023
295 LYMPHOMA 35 0.0023
296 HEPATIC FUNCTION ABNORMAL 84 0.0022
297 INCORRECT DOSAGE ADMINISTERED 11 0.0022
298 ISCHAEMIC STROKE 40 0.0022
299 ACUTE MYOCARDIAL INFARCTION 66 0.0022
300 SKIN HAEMORRHAGE 33 0.0022
301 GINGIVITIS 12 0.0022
302 DEAFNESS 58 0.0022
303 PAPILLOEDEMA 10 0.0022
304 GENERAL PHYSICAL CONDITION ABNORMAL 15 0.0022
305 NORMAL NEWBORN 12 0.0022
306 HEPATOTOXICITY 49 0.0022
307 HAIR GROWTH ABNORMAL 15 0.0022
308 SYNOVIAL CYST 10 0.0022
309 SUBARACHNOID HAEMORRHAGE 22 0.0022
310 PRODUCT DISTRIBUTION ISSUE 20 0.0022
311 LEUKOCYTOSIS 39 0.0022
312 BACTERIAL SEPSIS 7 0.0021
313 PERFORMANCE STATUS DECREASED 10 0.0021
314 PRODUCT PRESCRIBING ERROR 51 0.0021
315 WHITE BLOOD CELL COUNT INCREASED 82 0.0021
316 VIRAL INFECTION 71 0.0021
317 CHROMATURIA 48 0.0021
318 COVID-19 PNEUMONIA 25 0.0021
319 POOR PERIPHERAL CIRCULATION 9 0.0021
320 UTERINE HAEMORRHAGE 9 0.0021
321 FEBRILE NEUTROPENIA 140 0.0021
322 HEPATIC PAIN 9 0.0021
323 NEUTROPENIC SEPSIS 15 0.0021
324 LIMB INJURY 57 0.0021
325 POLYURIA 17 0.0021
326 ASCITES 61 0.0021
327 HEPATITIS C 25 0.0021
328 STAPHYLOCOCCAL BACTERAEMIA 9 0.0021
329 B-CELL LYMPHOMA 7 0.0021
330 WHITE BLOOD CELL COUNT DECREASED 222 0.0020
331 DISEASE PROGRESSION 240 0.0020
332 BLOOD CREATININE ABNORMAL 7 0.0020
333 LOW BIRTH WEIGHT BABY 16 0.0020
334 CAROTID ARTERY STENOSIS 7 0.0020
335 SUSPECTED OFF LABEL USE 9 0.0020
336 BACTERIAL INFECTION 37 0.0020
337 BONE PAIN 116 0.0020
338 FIBRIN D DIMER INCREASED 7 0.0020
339 NO THERAPEUTIC RESPONSE 24 0.0020
340 RECURRENT CANCER 8 0.0020
341 ANAEMIA 369 0.0019
342 BRONCHOPULMONARY ASPERGILLOSIS 15 0.0019
343 TREATMENT FAILURE 160 0.0019
344 IMMUNOSUPPRESSION 17 0.0019
345 HOSPITALISATION 296 0.0019
346 PULMONARY HAEMORRHAGE 15 0.0019
347 TONSILLITIS 10 0.0019
348 GASTROINTESTINAL INFECTION 17 0.0019
349 FEAR 51 0.0019
350 CATARACT 112 0.0019
351 WHITE BLOOD CELL COUNT ABNORMAL 12 0.0019
352 HYPOVOLAEMIC SHOCK 9 0.0019
353 CARDIAC FAILURE CHRONIC 8 0.0019
354 EYE HAEMORRHAGE 25 0.0019
355 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 14 0.0019
356 SKIN DISCOLOURATION 85 0.0018
357 HAEMORRHOIDAL HAEMORRHAGE 9 0.0018
358 INFECTION 265 0.0018
359 HYPOGAMMAGLOBULINAEMIA 12 0.0018
360 INTESTINAL ISCHAEMIA 10 0.0018
361 FLANK PAIN 17 0.0018
362 BLOOD CREATINE INCREASED 8 0.0018
363 APHTHOUS ULCER 14 0.0018
364 MULTIPLE ORGAN DYSFUNCTION SYNDROME 51 0.0018
365 RHINOVIRUS INFECTION 7 0.0018
366 LIVER INJURY 44 0.0018
367 MYALGIA 304 0.0018
368 KLEBSIELLA INFECTION 9 0.0018
369 INFLUENZA 198 0.0018
370 HIP FRACTURE 57 0.0018
371 ALANINE AMINOTRANSFERASE INCREASED 108 0.0018
372 PREMATURE DELIVERY 28 0.0018
373 JOINT EFFUSION 12 0.0017
374 FUNGAL SKIN INFECTION 7 0.0017
375 FAILURE TO THRIVE 9 0.0017
376 SYSTEMIC LUPUS ERYTHEMATOSUS 61 0.0017
377 ASPARTATE AMINOTRANSFERASE INCREASED 91 0.0017
378 ABNORMAL FAECES 14 0.0017
379 RETINAL HAEMORRHAGE 12 0.0017
380 OVERWEIGHT 9 0.0017
381 COVID-19 293 0.0017
382 PYREXIA 570 0.0016
383 QUALITY OF LIFE DECREASED 22 0.0016
384 HAEMATURIA 56 0.0016
385 SEPTIC SHOCK 71 0.0016
386 SKIN HYPERPIGMENTATION 14 0.0016
387 MENTAL STATUS CHANGES 45 0.0016
388 NEOPLASM MALIGNANT 108 0.0016
389 PALLOR 44 0.0016
390 DRUG INTOLERANCE 156 0.0016
391 ABDOMINAL TENDERNESS 8 0.0016
392 HEADACHE 1009 0.0016
393 MALNUTRITION 18 0.0016
394 BLOOD IRON DECREASED 19 0.0016
395 EPSTEIN-BARR VIRUS INFECTION 10 0.0016
396 HYPERAMMONAEMIA 8 0.0016
397 DRUG RESISTANCE 41 0.0016
398 PNEUMONIA 514 0.0016
399 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
400 KIDNEY INFECTION 31 0.0016
401 ACUTE CORONARY SYNDROME 13 0.0016
402 SKIN ATROPHY 9 0.0016
403 HEPATITIS ACUTE 10 0.0015
404 PARALYSIS 22 0.0015
405 SPINAL PAIN 18 0.0015
406 DRUG INEFFECTIVE 2019 0.0015
407 VITREOUS FLOATERS 15 0.0015
408 RENAL DISORDER 71 0.0015
409 MOUTH ULCERATION 32 0.0015
410 PERIPHERAL SWELLING 233 0.0015
411 GINGIVAL PAIN 12 0.0015
412 EATING DISORDER 32 0.0015
413 VISUAL IMPAIRMENT 186 0.0015
414 TERMINAL STATE 10 0.0015
415 LYMPHOPENIA 21 0.0015
416 HAEMOPTYSIS 41 0.0015
417 FATIGUE 1143 0.0015
418 ASTHENIA 546 0.0015
419 JOINT INJURY 31 0.0014
420 PRESCRIBED OVERDOSE 28 0.0014
421 CHOLECYSTITIS 17 0.0014
422 HEAD INJURY 45 0.0014
423 CHOLECYSTITIS ACUTE 8 0.0014
424 GENERAL PHYSICAL HEALTH DETERIORATION 163 0.0014
425 IMMUNODEFICIENCY 21 0.0014
426 MELAENA 31 0.0014
427 ANEURYSM 7 0.0014
428 HYPERNATRAEMIA 7 0.0014
429 PSEUDOMONAS INFECTION 12 0.0014
430 ILL-DEFINED DISORDER 85 0.0014
431 PRODUCT DOSE OMISSION ISSUE 411 0.0014
432 GASTRIC HAEMORRHAGE 16 0.0014
433 TOXIC SKIN ERUPTION 14 0.0014
434 CEREBROVASCULAR ACCIDENT 235 0.0014
435 RENAL CYST 11 0.0014
436 ANGINA UNSTABLE 9 0.0014
437 MALAISE 606 0.0014
438 DEPRESSED MOOD 73 0.0014
439 DYSPHAGIA 131 0.0014
440 APATHY 20 0.0014
441 ALOPECIA 269 0.0014
442 BLOOD URINE PRESENT 26 0.0014
443 HAEMATOTOXICITY 13 0.0014
444 LYMPHOCYTE COUNT DECREASED 24 0.0014
445 LYMPHADENOPATHY 48 0.0014
446 ASPHYXIA 11 0.0013
447 HEPATIC STEATOSIS 25 0.0013
448 ODYNOPHAGIA 8 0.0013
449 RENAL IMPAIRMENT 112 0.0013
450 ABDOMINAL DISCOMFORT 223 0.0013
451 HEMIPLEGIA 11 0.0013
452 AMNESIA 86 0.0013
453 CLOSTRIDIUM DIFFICILE COLITIS 14 0.0013
454 URINARY TRACT INFECTION 225 0.0013
455 LIGAMENT SPRAIN 13 0.0013
456 NEPHROTIC SYNDROME 9 0.0013
457 OVARIAN CYST 13 0.0013
458 RENAL FAILURE CHRONIC 10 0.0013
459 PREMATURE BABY 39 0.0013
460 FACIAL PARALYSIS 11 0.0013
461 HEPATITIS 33 0.0013
462 TOOTH ABSCESS 13 0.0013
463 DIARRHOEA 824 0.0013
464 ASTHENOPIA 7 0.0013
465 CYANOSIS 20 0.0013
466 CELLULITIS 64 0.0013
467 GASTROINTESTINAL HAEMORRHAGE 105 0.0013
468 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 226 0.0013
469 BLOOD ALKALINE PHOSPHATASE INCREASED 31 0.0012
470 ACUTE PULMONARY OEDEMA 7 0.0012
471 DIABETES MELLITUS 95 0.0012
472 FAECES DISCOLOURED 27 0.0012
473 ORAL DISORDER 9 0.0012
474 GOUT 22 0.0012
475 PAIN IN EXTREMITY 360 0.0012
476 NEOPLASM 14 0.0012
477 BLOOD CREATININE INCREASED 79 0.0012
478 DECREASED APPETITE 281 0.0012
479 HYDRONEPHROSIS 9 0.0012
480 MENINGITIS 8 0.0012
481 HAEMATOCHEZIA 66 0.0012
482 ACUTE RESPIRATORY FAILURE 23 0.0012
483 IRON DEFICIENCY ANAEMIA 11 0.0012
484 CHOLELITHIASIS 39 0.0012
485 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 240 0.0012
486 HAEMATEMESIS 30 0.0012
487 TASTE DISORDER 24 0.0012
488 INCORRECT DOSE ADMINISTERED 270 0.0012
489 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 7 0.0012
490 CATARACT OPERATION 7 0.0012
491 RHINORRHOEA 76 0.0012
492 THIRST 21 0.0012
493 RASH MACULAR 41 0.0012
494 ACCIDENT 14 0.0012
495 PROTHROMBIN TIME PROLONGED 7 0.0012
496 DYSPHONIA 68 0.0012
497 GANGRENE 7 0.0012
498 ATRIAL FIBRILLATION 113 0.0012
499 FLUID RETENTION 59 0.0012
500 BLOOD PRESSURE ABNORMAL 23 0.0012
501 THERAPY CESSATION 59 0.0011
502 PRODUCT DISPENSING ERROR 25 0.0011
503 COLON CANCER 17 0.0011
504 BLOOD CALCIUM INCREASED 10 0.0011
505 GASTRITIS 30 0.0011
506 ATELECTASIS 11 0.0011
507 RESPIRATORY FAILURE 83 0.0011
508 OFF LABEL USE 995 0.0011
509 FEEDING DISORDER 23 0.0011
510 THERAPY INTERRUPTED 81 0.0011
511 ABDOMINAL PAIN UPPER 233 0.0011
512 PULMONARY TOXICITY 8 0.0011
513 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
514 GENERALISED OEDEMA 14 0.0011
515 HAND FRACTURE 8 0.0011
516 BLINDNESS 46 0.0011
517 ABSCESS 18 0.0011
518 APHASIA 34 0.0011
519 RASH MACULO-PAPULAR 25 0.0011
520 STAPHYLOCOCCAL INFECTION 37 0.0011
521 LOCALISED INFECTION 27 0.0011
522 MYELOSUPPRESSION 40 0.0011
523 PHOTOPSIA 7 0.0011
524 TACHYPNOEA 15 0.0011
525 LIMB DISCOMFORT 34 0.0011
526 HEPATIC CYTOLYSIS 14 0.0011
527 HERPES ZOSTER 63 0.0011
528 GASTROENTERITIS 16 0.0011
529 EYE DISORDER 36 0.0011
530 LOCAL SWELLING 19 0.0011
531 BRAIN NEOPLASM 10 0.0011
532 MATERNAL EXPOSURE DURING PREGNANCY 97 0.0011
533 INFLAMMATION 56 0.0011
534 GAMMA-GLUTAMYLTRANSFERASE INCREASED 24 0.0011
535 DIPLOPIA 28 0.0011
536 HUNGER 15 0.0011
537 BLOOD UREA INCREASED 18 0.0011
538 APHONIA 15 0.0011
539 NEUTROPHIL COUNT INCREASED 11 0.0011
540 VISION BLURRED 147 0.0011
541 APPENDICITIS 10 0.0011
542 SPEECH DISORDER 56 0.0011
543 SWELLING 100 0.0011
544 EYE INFECTION 12 0.0011
545 ENCEPHALOPATHY 26 0.0011
546 OROPHARYNGEAL PAIN 98 0.0011
547 HEPATOCELLULAR INJURY 15 0.0011
548 APPETITE DISORDER 7 0.0011
549 COUGH 296 0.0011
550 MEMORY IMPAIRMENT 145 0.0011
551 NAUSEA 835 0.0011
552 CLOSTRIDIUM DIFFICILE INFECTION 23 0.0011
553 TROPONIN INCREASED 8 0.0011
554 CYTOKINE RELEASE SYNDROME 21 0.0010
555 BOWEL MOVEMENT IRREGULARITY 8 0.0010
556 BLOOD MAGNESIUM DECREASED 9 0.0010
557 DEVICE RELATED INFECTION 16 0.0010
558 FEELING ABNORMAL 249 0.0010
559 GLAUCOMA 20 0.0010
560 COLITIS ISCHAEMIC 7 0.0010
561 TRANSIENT ISCHAEMIC ATTACK 35 0.0010
562 HYPERTHYROIDISM 15 0.0010
563 ADVERSE DRUG REACTION 93 0.0010
564 DERMATITIS ALLERGIC 13 0.0010
565 POST PROCEDURAL HAEMORRHAGE 12 0.0010
566 HYPOALBUMINAEMIA 8 0.0010
567 ABDOMINAL DISTENSION 107 0.0010
568 DRUG-INDUCED LIVER INJURY 32 0.0010
569 HYPERTENSION 216 0.0010
570 PERIPHERAL COLDNESS 14 0.0010
571 ARTERIAL OCCLUSIVE DISEASE 8 0.0010
572 ONYCHOCLASIS 7 0.0010
573 HEAD DISCOMFORT 18 0.0010
574 DYSPEPSIA 100 0.0010
575 MIGRAINE 97 0.0010
576 VAGINAL HAEMORRHAGE 44 0.0010
577 PRODUCT USE ISSUE 189 0.0010
578 DYSURIA 37 0.0010
579 THROAT IRRITATION 45 0.0010
580 WRIST FRACTURE 12 0.0010
581 ARTHRALGIA 416 0.0010
582 FALL 332 0.0010
583 DIZZINESS 496 0.0010
584 PAPULE 7 0.0010
585 STENT PLACEMENT 8 0.0010
586 CONFUSIONAL STATE 160 0.0010
587 POST PROCEDURAL INFECTION 8 0.0010
588 HERNIA 19 0.0010
589 ORAL PAIN 22 0.0010
590 RENAL FAILURE 130 0.0010
591 PANCREATITIS ACUTE 22 0.0010
592 BLOOD CALCIUM DECREASED 11 0.0010
593 NEUTROPENIA 133 0.0010
594 DRUG ADMINISTRATION ERROR 30 0.0010
595 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 7 0.0010
596 UROSEPSIS 9 0.0010
597 HICCUPS 8 0.0010
598 MYOCARDIAL INFARCTION 170 0.0010
599 DIVERTICULITIS 27 0.0010
600 EAR DISCOMFORT 10 0.0010
601 PLEURAL EFFUSION 59 0.0010
602 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
603 BACK PAIN 225 0.0010
604 PHARYNGITIS 12 0.0010
605 MENSTRUAL DISORDER 8 0.0010
606 HYPOKINESIA 14 0.0010
607 FAECES SOFT 7 0.0010
608 SECOND PRIMARY MALIGNANCY 8 0.0010
609 PNEUMONIA ASPIRATION 24 0.0010
610 TENDERNESS 10 0.0010
611 CHILLS 112 0.0010
612 MUCOSAL INFLAMMATION 25 0.0010
613 RECTAL HAEMORRHAGE 41 0.0010
614 ACUTE HEPATIC FAILURE 13 0.0010
615 BLINDNESS TRANSIENT 7 0.0009
616 SUDDEN DEATH 10 0.0009
617 PULMONARY MASS 14 0.0009
618 TOOTHACHE 17 0.0009
619 ACUTE KIDNEY INJURY 143 0.0009
620 CARDIAC FAILURE 75 0.0009
621 CARDIO-RESPIRATORY ARREST 39 0.0009
622 NIGHT SWEATS 30 0.0009
623 CARDIAC OPERATION 8 0.0009
624 MASS 13 0.0009
625 GAIT INABILITY 31 0.0009
626 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
627 OEDEMA 50 0.0009
628 SKIN SWELLING 8 0.0009
629 RESPIRATORY TRACT INFECTION 24 0.0009
630 MACULAR DEGENERATION 11 0.0009
631 RASH 401 0.0009
632 CHEST PAIN 170 0.0009
633 WEIGHT DECREASED 256 0.0009
634 NASOPHARYNGITIS 169 0.0009
635 PULMONARY HYPERTENSION 19 0.0009
636 BLOOD TRIGLYCERIDES INCREASED 16 0.0009
637 DRY MOUTH 73 0.0009
638 ABDOMINAL PAIN 209 0.0009
639 FRACTURE 17 0.0009
640 VOMITING 422 0.0009
641 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
642 FLUID OVERLOAD 13 0.0009
643 SNEEZING 20 0.0009
644 GASTROENTERITIS VIRAL 16 0.0009
645 POOR QUALITY SLEEP 19 0.0009
646 BLOOD ALBUMIN DECREASED 7 0.0009
647 HYPOXIA 31 0.0009
648 HYPOTHYROIDISM 28 0.0009
649 HELICOBACTER INFECTION 9 0.0009
650 SWELLING FACE 57 0.0009
651 OSTEOPOROSIS 36 0.0009
652 HAEMORRHOIDS 17 0.0009
653 MUSCULOSKELETAL DISCOMFORT 15 0.0009
654 PLASMA CELL MYELOMA 34 0.0009
655 OEDEMA PERIPHERAL 106 0.0009
656 RESPIRATORY DISORDER 26 0.0009
657 PERITONITIS 18 0.0009
658 MUSCLE ATROPHY 11 0.0009
659 RHINITIS 7 0.0009
660 NERVE COMPRESSION 8 0.0009
661 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 61 0.0009
662 DRUG INTERACTION 136 0.0009
663 BLISTER 48 0.0009
664 UPPER LIMB FRACTURE 17 0.0009
665 PANCREATITIS 45 0.0009
666 HYPERGLYCAEMIA 31 0.0008
667 NEPHROLITHIASIS 39 0.0008
668 ARTERIOSCLEROSIS 8 0.0008
669 BLOOD SODIUM DECREASED 16 0.0008
670 MOOD SWINGS 27 0.0008
671 PNEUMONITIS 23 0.0008
672 COLITIS 32 0.0008
673 MUSCULOSKELETAL CHEST PAIN 13 0.0008
674 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
675 PRURITUS 322 0.0008
676 JOINT SWELLING 101 0.0008
677 CANDIDA INFECTION 14 0.0008
678 MUSCULAR WEAKNESS 94 0.0008
679 INSOMNIA 220 0.0008
680 PERICARDIAL EFFUSION 19 0.0008
681 FREQUENT BOWEL MOVEMENTS 22 0.0008
682 STOMATITIS 49 0.0008
683 PYELONEPHRITIS 7 0.0008
684 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
685 AGEUSIA 20 0.0008
686 NASAL CONGESTION 47 0.0008
687 BURNING SENSATION 56 0.0008
688 PHOTOPHOBIA 15 0.0008
689 PRODUCT DOSE OMISSION 52 0.0008
690 ADVERSE EVENT 73 0.0008
691 BRAIN OEDEMA 10 0.0008
692 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
693 POLLAKIURIA 33 0.0008
694 SYNCOPE 79 0.0008
695 TREATMENT NONCOMPLIANCE 43 0.0008
696 NERVOUSNESS 41 0.0008
697 CARDIAC DISORDER 73 0.0008
698 BLINDNESS UNILATERAL 11 0.0008
699 INITIAL INSOMNIA 8 0.0008
700 LUNG DISORDER 38 0.0008
701 OROPHARYNGEAL DISCOMFORT 7 0.0008
702 CONSTIPATION 169 0.0008
703 DRUG DOSE OMISSION 128 0.0008
704 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
705 VASCULITIS 9 0.0008
706 CRYING 28 0.0008
707 NODULE 10 0.0008
708 BLOOD POTASSIUM DECREASED 23 0.0008
709 MENORRHAGIA 15 0.0008
710 CIRCULATORY COLLAPSE 13 0.0008
711 CARDIAC ARREST 63 0.0008
712 RESPIRATORY DISTRESS 21 0.0008
713 ORAL CANDIDIASIS 10 0.0008
714 SCRATCH 8 0.0008
715 MENTAL DISORDER 33 0.0008
716 INTENTIONAL PRODUCT USE ISSUE 66 0.0008
717 MUSCLE SPASMS 137 0.0007
718 PRODUCT ADMINISTRATION ERROR 15 0.0007
719 FLATULENCE 42 0.0007
720 SHOCK 17 0.0007
721 SPINAL DISORDER 7 0.0007
722 SPUTUM DISCOLOURED 7 0.0007
723 PULMONARY OEDEMA 33 0.0007
724 MOOD ALTERED 20 0.0007
725 CHOLESTASIS 14 0.0007
726 GALLBLADDER DISORDER 13 0.0007
727 GASTROINTESTINAL DISORDER 65 0.0007
728 BLOOD PRESSURE DECREASED 48 0.0007
729 CYSTITIS 23 0.0007
730 FUNGAL INFECTION 24 0.0007
731 DRUG DISPENSING ERROR 11 0.0007
732 OSTEOMYELITIS 13 0.0007
733 CHOKING 14 0.0007
734 DYSPNOEA EXERTIONAL 27 0.0007
735 MOVEMENT DISORDER 23 0.0007
736 WOUND 20 0.0007
737 UPPER RESPIRATORY TRACT INFECTION 33 0.0007
738 FOETAL EXPOSURE DURING PREGNANCY 58 0.0007
739 MICTURITION URGENCY 8 0.0007
740 GAIT DISTURBANCE 134 0.0007
741 PRODUCT USE COMPLAINT 11 0.0007
742 ANGINA PECTORIS 20 0.0007
743 SKIN LESION 19 0.0007
744 PRODUCT PRESCRIBING ISSUE 15 0.0007
745 DISCOMFORT 42 0.0007
746 ARTHRITIS 54 0.0007
747 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
748 CARDIAC FAILURE CONGESTIVE 55 0.0007
749 GASTRIC ULCER 13 0.0007
750 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 20 0.0007
751 LUNG NEOPLASM MALIGNANT 28 0.0007
752 CONDITION AGGRAVATED 207 0.0007
753 BLOOD PRESSURE INCREASED 104 0.0007
754 HYPERSENSITIVITY 126 0.0007
755 LETHARGY 39 0.0007
756 LOWER LIMB FRACTURE 13 0.0007
757 BACK DISORDER 11 0.0007
758 PAIN 415 0.0007
759 NO ADVERSE EVENT 122 0.0007
760 GASTRIC DISORDER 23 0.0007
761 TREMOR 111 0.0007
762 EAR PAIN 13 0.0007
763 RASH PRURITIC 36 0.0007
764 DYSARTHRIA 25 0.0007
765 LEUKOPENIA 33 0.0007
766 C-REACTIVE PROTEIN INCREASED 24 0.0007
767 SKIN ULCER 17 0.0007
768 SINUS DISORDER 13 0.0007
769 CENTRAL NERVOUS SYSTEM LESION 9 0.0007
770 SMALL INTESTINAL OBSTRUCTION 8 0.0006
771 BLOOD GLUCOSE ABNORMAL 12 0.0006
772 HEMIPARESIS 11 0.0006
773 DECREASED ACTIVITY 7 0.0006
774 PARAESTHESIA 102 0.0006
775 DEHYDRATION 86 0.0006
776 ILEUS 8 0.0006
777 HYPOAESTHESIA 96 0.0006
778 SLEEP DISORDER 45 0.0006
779 SURGERY 37 0.0006
780 PNEUMOTHORAX 10 0.0006
781 HYPOKALAEMIA 29 0.0006
782 NECK PAIN 35 0.0006
783 METASTASES TO LIVER 11 0.0006
784 DYSPNOEA 354 0.0006
785 OCULAR DISCOMFORT 7 0.0006
786 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
787 DRUG ERUPTION 11 0.0006
788 UNRESPONSIVE TO STIMULI 16 0.0006
789 INTERSTITIAL LUNG DISEASE 30 0.0006
790 SCAB 7 0.0006
791 CHOLECYSTECTOMY 7 0.0006
792 FEELING COLD 17 0.0006
793 INFLUENZA LIKE ILLNESS 50 0.0006
794 TOOTH INFECTION 8 0.0006
795 SINUSITIS 62 0.0006
796 SKIN DISORDER 20 0.0006
797 HYPOGLYCAEMIA 29 0.0006
798 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 31 0.0006
799 FACE OEDEMA 10 0.0006
800 SINUS CONGESTION 8 0.0006
801 MUSCULOSKELETAL PAIN 31 0.0006
802 ANXIETY 168 0.0006
803 SEIZURE 68 0.0006
804 INSURANCE ISSUE 9 0.0006
805 CORONARY ARTERY OCCLUSION 8 0.0006
806 ANKLE FRACTURE 9 0.0006
807 LUNG INFECTION 9 0.0006
808 URTICARIA 97 0.0006
809 MULTI-ORGAN FAILURE 10 0.0006
810 SLEEP APNOEA SYNDROME 11 0.0006
811 WEIGHT INCREASED 129 0.0006
812 FIBROMYALGIA 14 0.0006
813 INCREASED APPETITE 11 0.0006
814 ORAL DISCOMFORT 8 0.0006
815 VERTIGO 35 0.0006
816 VISUAL ACUITY REDUCED 19 0.0006
817 JOINT STIFFNESS 15 0.0006
818 OCULAR HYPERAEMIA 27 0.0006
819 ULCER 9 0.0006
820 RENAL FAILURE ACUTE 24 0.0006
821 SEASONAL ALLERGY 8 0.0006
822 OBESITY 9 0.0006
823 PAIN IN JAW 16 0.0006
824 RASH ERYTHEMATOUS 27 0.0006
825 SCIATICA 9 0.0006
826 EAR INFECTION 15 0.0006
827 CARDIOGENIC SHOCK 8 0.0006
828 COGNITIVE DISORDER 26 0.0006
829 PRURITUS GENERALISED 12 0.0006
830 DRY SKIN 74 0.0006
831 ACNE 42 0.0006
832 DYSSTASIA 16 0.0005
833 NERVOUS SYSTEM DISORDER 17 0.0005
834 PRODUCTIVE COUGH 26 0.0005
835 METASTASES TO CENTRAL NERVOUS SYSTEM 7 0.0005
836 BLOOD GLUCOSE DECREASED 26 0.0005
837 THINKING ABNORMAL 10 0.0005
838 BLOOD CHOLESTEROL INCREASED 25 0.0005
839 PERICARDITIS 9 0.0005
840 OXYGEN SATURATION DECREASED 30 0.0005
841 BEDRIDDEN 7 0.0005
842 BALANCE DISORDER 46 0.0005
843 IRRITABILITY 32 0.0005
844 LOSS OF CONSCIOUSNESS 68 0.0005
845 DISORIENTATION 21 0.0005
846 FOOT FRACTURE 10 0.0005
847 BRONCHITIS 39 0.0005
848 LACTIC ACIDOSIS 17 0.0005
849 HYPERSOMNIA 15 0.0005
850 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
851 TACHYCARDIA 45 0.0005
852 EYE PRURITUS 17 0.0005
853 FEELING HOT 31 0.0005
854 MOBILITY DECREASED 36 0.0005
855 DISTURBANCE IN ATTENTION 27 0.0005
856 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
857 RASH PAPULAR 11 0.0005
858 BODY TEMPERATURE INCREASED 10 0.0005
859 DELIRIUM 17 0.0005
860 OSTEONECROSIS 16 0.0005
861 RIB FRACTURE 10 0.0005
862 DYSGEUSIA 36 0.0005
863 AGRANULOCYTOSIS 9 0.0005
864 HEART RATE DECREASED 17 0.0005
865 EYE SWELLING 18 0.0005
866 DRUG LEVEL INCREASED 8 0.0005
867 ROAD TRAFFIC ACCIDENT 20 0.0005
868 BLOOD GLUCOSE INCREASED 90 0.0005
869 HYPOCALCAEMIA 9 0.0005
870 PROTEINURIA 9 0.0005
871 SOMNOLENCE 95 0.0005
872 POST PROCEDURAL COMPLICATION 9 0.0005
873 IRRITABLE BOWEL SYNDROME 10 0.0005
874 CORONARY ARTERY DISEASE 14 0.0005
875 DEPRESSION 105 0.0005
876 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
877 ORAL HERPES 9 0.0005
878 ORTHOSTATIC HYPOTENSION 8 0.0005
879 EPILEPSY 14 0.0005
880 HEPATIC CANCER 11 0.0005
881 PRESYNCOPE 11 0.0005
882 NEUROPATHY PERIPHERAL 43 0.0005
883 EJECTION FRACTION DECREASED 7 0.0004
884 MALIGNANT NEOPLASM PROGRESSION 46 0.0004
885 BASAL CELL CARCINOMA 7 0.0004
886 GLOSSODYNIA 10 0.0004
887 THERAPEUTIC PRODUCT EFFECT DECREASED 20 0.0004
888 URINARY INCONTINENCE 13 0.0004
889 HYPOTENSION 88 0.0004
890 RENAL INJURY 13 0.0004
891 RESPIRATORY ARREST 12 0.0004
892 ABNORMAL DREAMS 12 0.0004
893 EXPOSURE DURING PREGNANCY 27 0.0004
894 MUSCULOSKELETAL STIFFNESS 38 0.0004
895 CHEST DISCOMFORT 44 0.0004
896 METASTASES TO BONE 7 0.0004
897 HYPONATRAEMIA 24 0.0004
898 EYE PAIN 24 0.0004
899 OSTEOARTHRITIS 18 0.0004
900 PHOTOSENSITIVITY REACTION 7 0.0004
901 RETCHING 9 0.0004
902 INTENTIONAL DOSE OMISSION 12 0.0004
903 LIP SWELLING 14 0.0004
904 ERYTHEMA 86 0.0004
905 PANCREATIC CARCINOMA 12 0.0004
906 ANGER 14 0.0004
907 INJURY 29 0.0004
908 NEURALGIA 10 0.0004
909 METABOLIC ACIDOSIS 13 0.0004
910 ABASIA 10 0.0004
911 ECZEMA 21 0.0004
912 DRY EYE 20 0.0004
913 SPINAL FRACTURE 8 0.0004
914 HALLUCINATION 30 0.0004
915 LACRIMATION INCREASED 12 0.0004
916 AGITATION 29 0.0004
917 SKIN EXFOLIATION 33 0.0004
918 EMOTIONAL DISORDER 12 0.0004
919 TYPE 2 DIABETES MELLITUS 13 0.0004
920 PELVIC PAIN 7 0.0004
921 GASTROOESOPHAGEAL REFLUX DISEASE 31 0.0004
922 BONE DISORDER 7 0.0004
923 UNEVALUABLE EVENT 29 0.0004
924 DERMATITIS 8 0.0004
925 COMA 18 0.0004
926 CONJUNCTIVITIS 7 0.0004
927 INTESTINAL OBSTRUCTION 14 0.0004
928 MENTAL IMPAIRMENT 9 0.0004
929 TINNITUS 17 0.0004
930 MEDICATION ERROR 20 0.0004
931 URINARY RETENTION 12 0.0004
932 PALPITATIONS 42 0.0004
933 HOT FLUSH 27 0.0004
934 ABDOMINAL PAIN LOWER 9 0.0004
935 CHRONIC KIDNEY DISEASE 27 0.0004
936 RESTLESSNESS 13 0.0004
937 FEMUR FRACTURE 11 0.0004
938 CARDIOVASCULAR DISORDER 9 0.0004
939 HYPOPHAGIA 9 0.0004
940 RASH GENERALISED 9 0.0003
941 TOXICITY TO VARIOUS AGENTS 58 0.0003
942 PSYCHOTIC DISORDER 10 0.0003
943 ARRHYTHMIA 16 0.0003
944 MENSTRUATION IRREGULAR 9 0.0003
945 HYPERHIDROSIS 43 0.0003
946 HALLUCINATION, VISUAL 7 0.0003
947 INTENTIONAL PRODUCT MISUSE 29 0.0003
948 IMPAIRED WORK ABILITY 7 0.0003
949 HEART RATE INCREASED 32 0.0003
950 EXTRA DOSE ADMINISTERED 13 0.0003
951 HEART RATE IRREGULAR 7 0.0003
952 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
953 DYSKINESIA 12 0.0003
954 NEOPLASM PROGRESSION 10 0.0003
955 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
956 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
957 ABORTION SPONTANEOUS 11 0.0003
958 IMPAIRED HEALING 9 0.0003
959 DRUG EFFECT DECREASED 14 0.0003
960 BREAST CANCER 24 0.0003
961 HYPERKALAEMIA 9 0.0003
962 PRODUCT STORAGE ERROR 21 0.0002
963 OVERDOSE 51 0.0002
964 CONVULSION 13 0.0002
965 WHEEZING 13 0.0002
966 SKIN IRRITATION 10 0.0002
967 INFUSION RELATED REACTION 14 0.0002
968 EYE IRRITATION 12 0.0002
969 ASTHMA 23 0.0002
970 NIGHTMARE 7 0.0002
971 COLITIS ULCERATIVE 9 0.0002
972 ARTHROPATHY 11 0.0002
973 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
974 RHABDOMYOLYSIS 8 0.0002
975 ACCIDENTAL OVERDOSE 7 0.0002
976 PROSTATE CANCER 15 0.0002
977 ANAPHYLACTIC REACTION 10 0.0002
978 BRADYCARDIA 9 0.0002
979 MULTIPLE SCLEROSIS 8 0.0002
980 SKIN BURNING SENSATION 11 0.0002
981 BLADDER CANCER 9 0.0002
982 AGGRESSION 7 0.0001
983 UNDERDOSE 10 0.0001
984 DRUG DEPENDENCE 20 0.0001
985 FLUSHING 12 0.0001
986 PSORIASIS 13 0.0001
987 RHEUMATOID ARTHRITIS 9 0.0001
988 EMOTIONAL DISTRESS 8 0.0001
989 INJECTION SITE PAIN 9 0.0000